Starling Oncology Executive and Leadership Team

Paul Johnson, the Chief Executive Officer at Starling Oncology, directs the overarching strategic vision for value-based cancer care delivery. This leadership role involves scaling the integrated clinic network to ensure consistent, high-quality patient outcomes across all service regions. By aligning clinical excellence with operational efficiency, the Chief Executive Officer drives the organization toward sustainable growth and expanded access to specialized oncology services. Paul Johnson maintains close collaboration with the Board to refine the long-term mission of providing evidence-based treatments within a community-focused model. Through rigorous oversight of corporate initiatives, the Chief Executive Officer ensures that every clinic maintains the highest standards of patient care. This executive leadership position requires constant evaluation of market trends and healthcare policy to maintain a competitive edge in the oncology sector. Ultimately, the Chief Executive Officer secures the future of the company by fostering innovation in cancer treatment delivery and patient support systems.

Robert Carter, the Chief Financial Officer at Starling Oncology, governs the financial health and fiscal strategy of the organization. This role involves managing capital allocation, budgeting, and financial reporting to support the expansion of the oncology clinic network. By analyzing revenue streams from value-based care contracts, the Chief Financial Officer ensures the company maintains the necessary resources to invest in advanced clinical trials and patient care infrastructure. Robert Carter collaborates with the executive team to assess the financial viability of new market entries and service line expansions. This leadership position requires precise oversight of fiscal operations to ensure long-term sustainability and profitability. Through strategic financial planning, the Chief Financial Officer mitigates risk while identifying opportunities for growth within the competitive oncology landscape. By maintaining rigorous financial controls, the Chief Financial Officer provides the stability required for the organization to continue delivering high-quality, evidence-based cancer treatments to patients across the country.

Daniel Virnich, the Chief Operating Officer at Starling Oncology, manages the daily execution of clinical operations and service delivery across the entire provider network. Overseeing the integration of oncology treatments and transfusion services, the Chief Operating Officer ensures that every clinic functions with maximum efficiency and patient-centric focus. This role involves optimizing workflows to support clinical trials and coordinated care models, directly impacting the quality of service provided to patients. Daniel Virnich coordinates with regional leadership to standardize operational protocols, ensuring that the company maintains high performance across all geographic footprints. By streamlining administrative and clinical processes, the Chief Operating Officer reduces operational friction and enhances the overall patient experience. This leadership function requires constant monitoring of performance metrics to drive continuous improvement in care delivery. Through meticulous management of resources, the Chief Operating Officer supports the broader mission of delivering accessible, high-quality cancer care to diverse communities.

Stacy Constantine, the Regional President at Starling Oncology, oversees the operational performance and market growth within assigned geographic territories. This leadership role involves managing the day-to-day activities of clinics, ensuring that each location meets the company's high standards for patient care and clinical outcomes. By driving regional initiatives, the Regional President ensures that the integrated cancer care model effectively serves local communities. Stacy Constantine collaborates with the executive team to implement corporate strategies at the local level, adapting operational tactics to meet specific regional needs. This function requires constant monitoring of clinic performance, patient satisfaction, and provider engagement to maintain service quality. Through the effective management of regional resources, the Regional President supports the company's mission of expanding access to evidence-based oncology treatments. This leadership role remains vital for maintaining operational consistency and achieving growth targets across the designated service areas, ensuring that every clinic contributes to the overall success of the organization.

Dan Ayer, the Regional President at Starling Oncology, directs the strategic development and operational success of clinics within specific market segments. This leadership role involves cultivating relationships with local healthcare providers and ensuring the seamless delivery of oncology services to patients. By focusing on regional market penetration, the Regional President expands the reach of the company's value-based care model. Dan Ayer monitors clinical performance metrics and operational efficiency to ensure that each facility within the region adheres to the organization's evidence-based treatment standards. This executive function requires constant coordination with corporate leadership to align regional activities with the company's long-term growth objectives. Through the oversight of regional operations, the Regional President ensures that the organization remains responsive to the unique needs of the communities served. This leadership role drives the expansion of clinical trials and transfusion services, ultimately strengthening the company's position as a leader in integrated cancer care delivery.

Yale Podnos, the Chief Medical Officer at Starling Oncology, architects the clinical standards and evidence-based treatment protocols utilized across the entire network. This leadership role involves supervising the medical staff and ensuring that all clinical trials and patient care models adhere to the highest scientific benchmarks. By fostering a culture of clinical excellence, the Chief Medical Officer drives the adoption of innovative oncology therapies that improve patient survival rates and quality of life. Yale Podnos works closely with affiliated providers to ensure seamless coordination of care, particularly for complex cases requiring multi-disciplinary intervention. This executive function requires constant engagement with medical research and emerging oncology technologies to keep the organization at the forefront of cancer care. Through the oversight of clinical quality and safety, the Chief Medical Officer ensures that every patient receives personalized, effective treatment. This leadership role remains central to the company's reputation for delivering superior, value-based oncology services.

Kristin England, the Chief Administrative Officer at Starling Oncology, directs the internal infrastructure and organizational support systems necessary for seamless clinic operations. This role involves managing human resources, corporate compliance, and administrative workflows that underpin the delivery of oncology services. By streamlining internal processes, the Chief Administrative Officer ensures that clinical teams possess the support required to focus entirely on patient care. Kristin England coordinates with other C-suite leaders to align administrative policies with the company's broader strategic goals. This leadership position requires constant attention to regulatory requirements and operational efficiency to maintain a high-functioning corporate environment. Through the implementation of robust administrative frameworks, the Chief Administrative Officer facilitates the scaling of the clinic network across various regions. This executive function supports the organization's mission by ensuring that all non-clinical operations remain efficient, compliant, and fully integrated with the overall model of value-based cancer care delivery.